Article
A Novel TRAF3IP2 Mutation Causing Chronic Mucocutaneous Candidiasis.
Journal of clinical immunology - 1 Aug 2021
Marujo Filipa, Pelham Simon J, Freixo João, Cordeiro Ana Isabel, Martins Catarina, Casanova Jean-Laurent, Lei Wei-Te, Puel Anne, Neves João Farela
Abstract excerpt
Inborn errors of the IL-17-mediated signaling have been associated with chronic mucocutaneous candidiasis (CMC). We describe a patient with CMC, atopic dermatitis, enamel dysplasia, and recurrent parotitis harboring a novel compound heterozygous mutation of TRAF3IP2, leading to autosomal recessive ACT1 deficiency and deficient IL-17 signaling.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
